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Abstract 
The authors discuss the potential influence of obesity surgery on the risk of cancer, focusing on the upper Gl 
tract directly affected by operations. There is currently no substantiation for an increased risk of cancer after 
bariatric surgery, because there are only about 25 reports of subsequent cancer of the esophagus and the stomach. 
However, this review emphasizes the need to detect potential precancerous conditions before surgery. 
Candidates for postoperative endoscopic surveillance may include patients >15 years after gastric surgery, but 
also patients symptomatic for gastroesophageal reflux disease in whom a high incidence of Barrett's metaplasia 
has been reported. The greatest concern is a delay in diagnosis from inadequate investigation due to mistaking 
serious upper Gl symptoms as a consequence of the past operation. 
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Introduction 
Surgery for morbid obesity is increasing in all industrialized countries and is becoming one of the most common 
types of surgery. The choice of operation depends primarily on the expected effect on the weight loss. A concern 
of the caring surgeon is to avoid harmful consequences to the patient as a result of the operation. While potential 
surgical and metabolic complications have been well-defined in the postoperative period, the risk of cancer 
associated with bariatric surgery in general and with specific operations remains unclear. 
This subject is relevant from the first contact with the obese patient, because the bariatric surgeon will treat and 
care for a population that presents an increased risk for the development of malignancy. Increased body weight 
has been found to be associated with increased death rates from cancer, most consistently from endometrium, 
kidney, gallbladder, breast, colon and esophagus.1,2 In a US prospective cohort study of over 900,000 patients,3 
the increased risk of obesity was identified for cancer of the esophagus, colon and rectum, liver, gallbladder, 
pancreas, kidney, non-Hodgkin lymphoma and multiple myeloma. In men, there was also a significant increased 
risk for cancer of the stomach and prostate, while in women, this risk was found for cancer of the breast, uterus, 
cervix and ovary. Potential etiologic mechanisms include increased levels of hormones associated with obesity 
(e.g. steroids, insulin, insulin-like growth factor I). 
Bariatric Surgery - Rationale for Cancer Risk 
Another concern rises from a potential influence of the bariatric operation on the development of cancer. 
This risk has been recognized in the gastric stump after gastrectomy for benign disease (peptic ulcer surgery), 
with a 3-5 fold increase after 15-25 years.4 While the prevalence of Billroth II operations appears higher in the 
reported cases of gastric stump carcinoma, it may only reflect its higher frequency compared to the Billroth I 
technique. In addition to time since initial surgery, suggested risk factors5 include sex (female), age at operation 
(old), and underlying disease (gastric ulcer). The discrepancies in the risk reported in the literature may reflect 
insufficient length of follow-up in many studies, in addition to potential environmental and ethnic factors.6 
The raised gastric pH associated with pancreatico-biliary reflux might lead to the bacterial colonization whose 
metabolism leads to production of carcinogens. The influence of Helicobacter pylori (HP) in the genesis of 
gastric pouch carcinoma is currently unsettled.4,7 The prevalence of HP after partial gastrectomy is <50% and 
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might be influenced by duodenogastric reflux.8 This bacterium has not been found to be specific in the patients 
presenting with dysplasia or adenocarcinoma of the gastric remnant, but in the endoscopic surveillance study 
after partial gastrectomy of Giuliani et al,9 the prevalence of intestinal metaplasia was four times higher in HP-
positive patients (19.6% vs 4.6%). Ebstein-Barr virus was also suggested as a potential co-factor by Yamamoto10 
et al associated with gastric remnant cancer after partial gastrectomy. 
Gastric Pouch Cancer after Gastric Bypass Procedures 
The above data on gastric remnant cancer after partial gastrectomy should apply to bariatric operations in which 
a loop jejunal anastomosis was performed on the gastric pouch (Mason loop gastric bypass). The procedure of 
Roux-en-Y gastric bypass (RYGBP) usually uses a long Roux loop of jejunum and should carry a different risk. 
This is suggested by the lesser incidence and severity of gastritis in the gastric remnant after gastrectomy for 
ulcer disease, if the gastric pouch is anastomosed to a Roux-en-Y loop compared to a loop gastroenterostomy.11 
Furthermore, atrophic gastritis which is frequent after a Billroth procedure, appears to be rare in the proximal 
pouch after a Roux-en-Y drainage.11,12 
McCarthy et al13 evaluated the gastric pouch of 28 patients after gastric bypass surgery according to the type of 
gastrojejunal anastomosis. They observed a 71% incidence of endoscopic gastritis after loop gastroenterostomy 
and 13% after RYGBP. Histologic examination of the mucosa demonstrated inflammation in 86% of the first 
group and 63% after RYGBP. Dysplasia was found in the biopsy specimens from the pouch, but their 
distribution according to the type of gastrointestinal anastomosis was not presented. No preoperative endoscopy 
had been performed, and with the short time interval between surgery and endoscopy (mean 8 months), it is 
difficult to ascertain the significance of the procedure in the changes observed. 
Only two cases of cancer in the gastric pouch have presently been reported. One pouch adenocarcinoma occurred 
in a 61-year old lady 26 years after a Mason loop gastric bypass.14 En bloc resection included pouch, bypassed 
stomach, and 10 cm of transverse colon, and none of the 14 lymph nodes were involved. Reconstruction was by 
esophago-jejunostomy, but long-term follow up is unknown. 
The other pouch carcinoma occurred in a 52-year-old lady who had initially undergone adjustable gastric 
banding complicated by gastric wall erosion that required band removal and conversion to RYGBP15 Five years 
later, she was diagnosed with a carcinoma of the pouch. 
Gastric Cancer in the Bypassed Stomach after Gastric Bypass 
The distal stomach after gastric bypass is also exposed to pancreaticobiliary reflux with pooled bile reported in 
the excluded stomach.16 Superficial gastritis of this segment is common. While Sinar et al16 reported that 
biopsies from the distal stomach in 4 of 33 patients showed intestinal dysplasia at 3-24 months after surgery, this 
was not observed in a later study with a 2 years follow-up by the same group.17 The risk of cancer of the 
bypassed segment cannot be derived from a similar operation and is unknown. The distal gastric segment is 
excluded from the alimentary channel and thus from contact with exogenous carcinogens. It could, however, 
suffer from prolonged contact with stagnant bile, shown experimentally to promote carcinogenesis.4 
Five cases of adenocarcinoma of the distal stomach have been reported after gastric bypass.18-22 Cancer was 
diagnosed at an advanced stage in four of the cases, 4,5, 8 and 22 years after the procedure. The patient with the 
carcinoma in the bypassed stomach at 4 years had had intestinal metaplasia and HP (given eradication therapy) 
on endoscopy before the RYGBP.18 Symptoms resulted from distal gastric outlet obstruction in three cases and 
were associated with tumor infiltration of liver in the fourth patient.21 A fifth patient presented with anemia that 
was investigated for 1 year before an endoscopy evaluated the distal stomach through the loop gastrojejunostomy 
and found two polypoid early gastric cancers.22 
The delay in diagnosis of cancer represents a risk for lesions arising in the excluded distal stomach that are more 
difficult to investigate. This is illustrated in the following case referred to our surgical department:23 A 66-year-
old male 3 years after RYGBP, was diagnosed with a gastric fundus perforation associated with a diffuse large 
B-cell lymphoma. The patient had a 6-month history of anemia with GI bleeds, with investigation by upper and 
lower endoscopy having been negative. The distal excluded stomach had not been investigated as the source of 
bleeding, because of the absence of knowledge of the persisting distal gastric segment after bypass surgery. 
Gastric lymphoma is a rare event, representing 3% of all gastric cancers.24 In the case described above, it is 
uncertain whether local conditions in the bypassed stomach played a role in the development of lymphoma. The 
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relatively short time interval between RYGBP and malignant transformation in our patient precludes a definitive 
answer. Lymphomas have been described in the proximal gastric stump 5 to 43 years after partial gastrectomy, 
with 15 cases reported in the Western literature and 27 cases in Japan.25,26 The proximal gastric stump after the 
partial gastrectomy and the distal gastric remnant after RYGBP may share in common an increased exposure to 
duodenal reflux with accompanying mucosal inflammation. It has been suggested that lymphocyte infiltration 
associated with chronic inflammation of the mucosa could develop into lymphoma. HP also plays an important 
role in the development of gastric lymphoma.27,28 Other factors, however, intervene, as there has been a low 
correlation between HP and lymphoma in the reported cases after partial gastrectomy. 
Gastric Cancer after Restrictive Operations 
A modification of the risk of gastric cancer by a purely restrictive procedure could result from prolonged contact 
of food and potential exogenous carcinogens in the gastric pouch. Increased pressure with chronic inflammation 
in the pouch could also be evoked as a potential factor for oncogenesis that can also include irritation by the 
banding material. These hypotheses remain speculative in view of the few cases of cancer reported in the 
literature. 
Four cases of adenocarcinoma have been described after vertical banded gastroplasty (VBG). Three occurred in 
the gastric pouch at 2, 13 and 15 years after surgery,29-31 while the fourth appeared in the distal stomach 6 years 
after VBG32 The patients presented with a history of epigastric pain, nausea and vomiting for a few weeks to 3 
months before diagnosis. Histological examination revealed a T1N0 adenocarcinoma in one case, but showed 
poorly differentiated adenocarcinoma with positive nodes in the other three patients, two with distant metastases. 
Ten years after adjustable gastric banding, a 62-year-old lady presented with band erosion amid gastric cancer.33 
Pathologic study demonstrated a poorly differentiated adenocarcinoma with positive perigastric nodes and 
hepatic metastases. 
The main risk of cancer associated with restrictive operations could derive from negligence of upper GI 
symptoms commonly observed after the operation that can delay diagnosis and treatment. This is shown in the 
following case report:23 A 47-year-old lady presented in our clinic after several months of progressive dysphagia 
with vomiting, 12 years after a VBG. These symptoms had been attributed to inadequate respect for dietetic rules 
after VBG. Endoscopy and barium studies demonstrated severe stenosis with a normal mucosa at the gastric 
pouch outlet. At laparotomy, a 9-cm intramural mass was found in the antrum, just below the pouch outlet, and 
was treated by total gastrectomy. Frozen section disclosed malignancy, and pathology diagnosis described a 
gastrointestinal stromal tumor (GIST). Recurrence was diagnosed in the lungs and liver 3 years later. 
GIST 
GISTs are the most common mesenchymal tumors of the GI tract, with 40-70% occurring in the stomach. The 
annual incidence of GIST (10 to 20 cases per million) is probably underestimated, because most patients with 
GIST are asymptomatic until late. Ten to 30% are discovered incidentally34 This is illustrated by Sanchez et al,35 
who reported a 0.8% incidence of GIST discovered incidentally during laparoscopic RYGBP upon inspection of 
the stomach before transection. All GISTs are currently considered to have some malignant potential.36 In view 
of their degenerative potential, the difficulty to define the risk of a specific lesion without histology, and the 
complexity of follow-up, it is recommended to remove any such lesion discovered incidentally during a bariatric 
operation. 
Esophageal Cancer after Bariatric Surgery 
A recent meta-analysis provides evidence for an association between BMI and esophageal adenocarcinoma.37 El-
Serag et al38 suggested that abdominal visceral adiposity might mediate most of the risk, showing a significant 
association with Barrett's esophagus in a model that adjusted for BMI. However, the mechanism by which this 
increased risk is mediated is not identified. Gastroesophageal reflux disease (GERD)39,40 and other factors such 
as hormonal, insulin, and dietetic have been proposed.41 
A high incidence of GERD has also been reported after bariatric surgery, with the risk to translate into a high 
incidence of Barrett's metaplasia in the midterm and esophageal carcinoma in the long-term. Gastric partitioning 
has the potential to increase the contact period between alimentary carcinogens, the lower esophagus, and the 
gastric pouch. 
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Malabsorptive operations including the use of a long Roux-en-Y loop appear to be associated with a lower 
incidence of reflux symptoms.42 Furthermore, if we accept, as suggested by several investigators,43,44 that the 
amount of acid secretion is pivotal for development of Barrett's esophagus, the risk of esophageal cancer could 
even be lower after this type of bariatric operation. This is supported by the study of Csendes et al45 who not only 
reported the suppression of GERD symptoms but also the regression of Barrett's metaplasia after RYGBR 
The effect of gastric restrictive procedures on gastroesophageal reflux is less clear. Studies report decreased, 
unchanged or increased acid exposure of the esophagus after surgery,46-48 but the incidence of esophagitis 
appears high in most reports. This variable effect on reflux probably reflects the influence of many factors. There 
are differences in the way a specific procedure is carried out by different surgeons (size of pouch, position of 
band). GERD will also depend on the alimentary compliance, reflecting the patient's capacity to follow the 
dietetic guidelines and also the education and surveillance by the team in charge of the follow-up. 
Four cases of adenocarcinoma of the gastroesophageal junction have been reported. One case was diagnosed 8 
years after adjustable gastric banding with liver metastases.49 Two cases were diagnosed 14 and 21 years after 
RYGBP;50 pathologic study evidenced a T1N0 lesion in the first RYGBP patient, while the second patient 
presented with an advanced cancer involving in the entire thoracic esophagus that recurred 8 months after 
resection. This latter patient had been diagnosed with dysplasia 26 months before cancer diagnosis but had failed 
to comply with the recommended follow-up. The fourth case of adenocarcinoma of the gastroesophageal 
junction extended to the lesser curvature of the stomach in a 57-year-old lady after two previous bariatric 
operations.50 Twenty-six years earlier, she had undergone a jejunoileal bypass which was reversed 8 years later 
for metabolic complications, followed by a VBG 16 years before cancer diagnosis. 
Discussion 
Despite the risk factors in the bariatric surgery population, few cases of cancer have been reported compared to 
the very large number of bariatric operations performed worldwide. Bariatric surgery may have decreased a 
number of risk factors for cancer, starting with elevated BMI. The time interval after surgery may, however, be 
too short to unveil an increased incidence of neoplasia. The low rate of cancer observed at present may also 
reflect the screening effect of preoperative evaluation. Prevention with careful preoperative evaluation appears to 
have a major role. It should start with a history for familial or patient conditions associated with a higher risk for 
cancer. Preoperative endoscopy is valuable to detect premalignant lesions such as metaplasia in the esophagus 
and stomach, for which adequate treatment or follow-up should be addressed. Presence of intestinal metaplasia 
in the stomach or early antral carcinoma in the massively obese individual should lead to strong consideration for 
prophylactic high subtotal or total gastrectomy performed using oncologic principles during RYGBP.51-53 The 
importance of preoperative endoscopy is supported by Sharaf et al54 who found that 90% of their 195 patients 
had one or more lesions, with 60% that changed or delayed the clinical approach, including 3% Barrett's 
esophagus. Similarly, preoperative endoscopic findings reported by Zeni et al55 from 169 patients, included in 
addition to two cases of Barrett's esophagus, one case of GIST and one case of gastric polyp that both 
necessitated a partial gastrectomy. The yield is higher if the endoscopy is symptom-oriented. Endoscopy before 
revisional surgery for symptomatic reflux after a gastric restrictive procedure found an incidence of Barrett's 
metaplasia in 28% of the patients.56 Although the influence of HP on the development of metaplasia and cancer 
after RYGBP is largely unknown, its demonstrated role in gastric cancer in the general population57 justifies its 
treatment if discovered during preoperative evaluation. 
Based on the few reported cases of cancer after bariatric surgery, evidence is lacking for the institution of a 
surveillance program started immediately after surgery. Continued careful reporting of complications is 
mandatory to delineate the risk associated with each type of bariatric operation, that could then be used to 
develop a surveillance algorithm for the specific populations. At present, candidates for postoperative 
endoscopic surveillance could include patients with a >15 year history after gastric surgery, but also patients 
symptomatic for GERD in whom a high incidence of Barrett's metaplasia has been reported. Routine 
preoperative evaluation and prompt postoperative investigation for modified or new symptoms presented by 
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